Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
KetaPal is a placebo-controlled randomized trial designed to demonstrate the antidepressant action of ketamine in palliative care situations. Half of participants will receive Ketamine and Milnacipran in combination, while the other half will receive a Placebo and Milnacipran in combination.
Epistemonikos ID: e719a3657344a9691b719e7396e060273d669990
First added on: May 13, 2024